X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24) 24
index medicus (20) 20
oncology (17) 17
animals (15) 15
hematology (13) 13
lymphoma (13) 13
cancer (12) 12
lymphomas (11) 11
mice (10) 10
radiotherapy (10) 10
immunotherapy (9) 9
female (8) 8
radiation therapy (8) 8
apoptosis (7) 7
chemotherapy (7) 7
non-hodgkins-lymphoma (7) 7
tumor cells, cultured (7) 7
antibodies, monoclonal - therapeutic use (6) 6
cell biology (6) 6
disease models, animal (6) 6
irradiation (6) 6
lymphoma, b-cell - immunology (6) 6
mice, inbred balb c (6) 6
polyploidy (6) 6
tumors (6) 6
aged (5) 5
antibodies, monoclonal - immunology (5) 5
care and treatment (5) 5
cd40 (5) 5
combined modality therapy (5) 5
male (5) 5
middle aged (5) 5
rituximab (5) 5
adult (4) 4
antibodies, monoclonal - pharmacology (4) 4
cd8-positive t-lymphocytes - immunology (4) 4
cell line, tumor (4) 4
clinical trials (4) 4
dendritic cells (4) 4
in-vivo (4) 4
lymphocytes (4) 4
radiation (4) 4
radioimmunotherapy (4) 4
therapy (4) 4
tumor-cells (4) 4
abridged index medicus (3) 3
activation (3) 3
aged, 80 and over (3) 3
antibody (3) 3
antineoplastic agents - therapeutic use (3) 3
breast-cancer (3) 3
cancer research (3) 3
cd40 antigens - immunology (3) 3
chronic lymphocytic-leukemia (3) 3
death (3) 3
expression (3) 3
flow cytometry (3) 3
genetics (3) 3
hematology, oncology and palliative medicine (3) 3
hodgkin's disease (3) 3
immunology (3) 3
lymphocyte activation - drug effects (3) 3
lymphocyte activation - immunology (3) 3
lymphocytes t (3) 3
lymphoma, b-cell - drug therapy (3) 3
lymphoma, b-cell - pathology (3) 3
lymphoma, b-cell - therapy (3) 3
medical research (3) 3
mitotic catastrophe (3) 3
monoclonal-antibodies (3) 3
neoplasms - immunology (3) 3
neoplasms - pathology (3) 3
neoplasms - radiotherapy (3) 3
neoplasms - therapy (3) 3
patients (3) 3
phase-i (3) 3
positron-emission-tomography (3) 3
radiology, nuclear medicine & medical imaging (3) 3
radiotherapy dosage (3) 3
t-cells (3) 3
tlr7 (3) 3
toll-like receptor 7 - agonists (3) 3
treatment outcome (3) 3
adenine - analogs & derivatives (2) 2
agonistic cd40 antibodies (2) 2
analysis (2) 2
anti-cd20 antibody (2) 2
anti-cd40 monoclonal-antibody (2) 2
antibodies, monoclonal - metabolism (2) 2
antibodies, monoclonal, murine-derived (2) 2
anticancer chemotherapy (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - pharmacology (2) 2
apoptosis - immunology (2) 2
apoptosis - physiology (2) 2
apoptosis - radiation effects (2) 2
article (2) 2
b-cell lymphoma (2) 2
b-lymphocytes - immunology (2) 2
b-lymphocytes - metabolism (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2017, Volume 390, Issue 10094, pp. 555 - 566
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2017, Volume 23, Issue 18, pp. 5514 - 5526
Purpose: Radiotherapy is a highly effective anticancer treatment forming part of the standard of care for the majority of patients, but local and distal... 
BREAST-CANCER | RESPONSES | ANTICANCER CHEMOTHERAPY | ONCOLOGY | LOCAL RADIATION | FTY720 | TUMOR | MICE | RADIOTHERAPY | DIFFERENTIATION | ANTIGEN | Neoplasms - metabolism | T-Lymphocyte Subsets - immunology | Humans | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Neoplasms - therapy | T-Lymphocyte Subsets - drug effects | Lymphocytes, Tumor-Infiltrating - metabolism | Disease Models, Animal | Antineoplastic Agents, Hormonal - pharmacology | Cytokines - metabolism | Programmed Cell Death 1 Receptor - metabolism | Survival Rate | T-Lymphocyte Subsets - radiation effects | Combined Modality Therapy | Lymphocytes, Tumor-Infiltrating - drug effects | Radiotherapy | Xenograft Model Antitumor Assays | Animals | Neoplasms - immunology | T-Lymphocyte Subsets - metabolism | Cell Line, Tumor | Mice | Receptors, Antigen, T-Cell, alpha-beta - metabolism | Neoplasms - pathology | Lymphocytes, Tumor-Infiltrating - radiation effects | Lymphocytes, Tumor-Infiltrating - immunology | Flow cytometry | Immune response | PD-1 protein | Trafficking | Radiation | Immune clearance | Lymphocytes T | T cell receptors | Radiation therapy | Immunity | Metastases | Anticancer properties | T-cell receptor | Cytometry | Immunogenicity | Experimental design | Lymphocytes | PD-L1 protein | Monoclonal antibodies | Infiltration | Lesions | Cancer
Journal Article
Nature Reviews Urology, ISSN 1759-4812, 04/2018, Volume 15, Issue 4, pp. 251 - 259
An urgent need exists to improve the outcomes of patients with muscle-invasive bladder cancer (MIBC), and especially of those with metastatic disease.... 
PHASE-III TRIAL | CALRETICULIN EXPOSURE | BACILLUS-CALMETTE-GUERIN | THERAPY | PD-L1 EXPRESSION | REGULATORY T-CELLS | EAU GUIDELINES | UROLOGY & NEPHROLOGY | METASTATIC UROTHELIAL CARCINOMA | I EXPRESSION | SINGLE-ARM | Care and treatment | Usage | Research | Radiotherapy | Bladder cancer | Patient outcomes | Ligands | Metastasis | Radiation therapy | Response rates | Apoptosis
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 11/2018, Volume 59, Issue 11, pp. 2519 - 2520
Journal Article
International Journal of Cancer, ISSN 0020-7136, 08/2014, Volume 135, Issue 4, pp. 820 - 829
Journal Article
Leukemia & lymphoma, 06/2018, p. 1
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1547 - 1547
Background The anti-PD1 antibodies nivolumab and pembrolizumab are approved for relapsed or refractory classical Hodgkin lymphoma (r/r cHL) due to high overall... 
Journal Article
FUTURE ONCOLOGY, ISSN 1479-6694, 12/2019, Volume 15, Issue 36, pp. 4223 - 4234
Sandoz rituximab (SDZ-RTX; Rixathon (R); GP2013), a rituximab biosimilar, was approved in June 2017 in Europe in all indications of reference rituximab. The... 
clinical | analytical | ONCOLOGY | preclinical | biosimilar medicines | CLINICIAN | non-Hodgkin lymphoma | SDZ-RTX | rheumatoid arthritis | FUCOSE | rituximab | totality of evidence | Index Medicus
Journal Article